LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the above captioned subject, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed a Press Release titled 'Lincoln Pharmaceuticals Ltd receives approval from Australian Regulator, TGA.' LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholding for the Period Ended September 30, 2021
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provision of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate as received from M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058 for the Quarter Ended September 30, 2021. Lincoln Pharmaceuticals Ltd - 531633 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NIREN ATINBHAI DESAIDesignation :- Company Secretary and Compliance Officer Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Outcome Of The Board Meeting
With reference to the above captioned subject, we would like to inform you that the board of directors of the Company at its meeting held today i.e. on Tuesday, October 05, 2021, which commenced at 5:30 p.m. and concluded at 6:20 p.m. inter-alia considered and approved the following: - Allotment of 29,728 equity shares of face value of Rs. 10/- each of the Company pursuant to the scheme of amalgamation of Lincoln Parenteral Limited (''Transferor Company'') and Lincoln Pharmaceuticals Limited (''Transferee Company'') and their respective shareholders and creditors ('Scheme'), as approved by the Hon''ble National Company Law Tribunal, Ahmedabad Bench vide its order dated September 14, 2021. Further, it is noted that the 98,58,438 (Ninety Eight Lacs Fifty Eight Thousand Four Hundred Thirty Eight) equity shares of Transferor Company held by the Company (Transferee Company) shall be cancelled without any act, deeds or instrument. LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lincoln Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to the provisions of Regulation 44 of SEBI (LODR) Regulations, 2015, we wish to inform you that 27th Annual General Meeting of the company was held on Thursday, September 30, 2021 at 11:00 a.m. through Video Conferencing (VC)/Other Audio Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We enclose herewith the details of the results of voting held through remote e-voting and e-voting at the AGM along with scrutinizer''s report on e-voting. Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Issue / Allot Equity Shares Pursuant To Scheme Of Amalgamation
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2021 ,inter alia, to consider and approve to issue / allot equity shares pursuant to scheme of amalgamation Lincoln Pharmaceuticals Ltd - 531633 - Shareholder Meeting / Postal Ballot-Outcome of AGM
In compliance of various circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India, the 27th AGM of the Company was held today i.e. Thursday, September 30, 2021 at 11: a.m. through VC / OAVM to seek the approval of members of the Company on resolutions set out in the Notice convening the Meeting. LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel